Statement of Changes in Beneficial Ownership (4)
September 06 2019 - 4:19PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Ferola Peter |
2. Issuer Name and Ticker or Trading Symbol
BIOTELEMETRY, INC.
[
BEAT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP & General Counsel
|
(Last)
(First)
(Middle)
1000 CEDAR HOLLOW RD. SUITE 102 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/4/2019
|
(Street)
MALVERN, PA 19355
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
9/4/2019
|
|
M
|
|
6835
|
A
|
$8.68
|
19622
|
D
|
|
Common Stock
|
9/4/2019
|
|
M
|
|
17751
|
A
|
$10.36
|
37373
|
D
|
|
Common Stock
|
9/4/2019
|
|
M
|
|
10293
|
A
|
$9.57
|
47666
|
D
|
|
Common Stock
|
9/4/2019
|
|
M
|
|
3264
|
A
|
$24.65
|
50930
|
D
|
|
Common Stock
|
9/4/2019
|
|
M
|
|
1853
|
A
|
$33.35
|
52783
|
D
|
|
Common Stock
|
9/4/2019
|
|
S(1)
|
|
44276
|
D
|
$39.03 (2)
|
8507
|
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Options (Right to Buy)
|
$8.68
|
9/4/2019
|
|
M
|
|
|
6835
|
(3)
|
2/14/2024
|
Common Stock
|
6835.0
|
$0
|
0
|
D
|
|
Stock Options (Right to Buy)
|
$10.36
|
9/4/2019
|
|
M
|
|
|
17751
|
(4)
|
2/16/2025
|
Common Stock
|
17751.0
|
$0
|
0
|
D
|
|
Stock Options (Right to Buy)
|
$9.57
|
9/4/2019
|
|
M
|
|
|
10293
|
(5)
|
2/15/2026
|
Common Stock
|
10293.0
|
$0
|
3433
|
D
|
|
Stock Options (Right to Buy)
|
$24.65
|
9/4/2019
|
|
M
|
|
|
3264
|
(6)
|
2/14/2027
|
Common Stock
|
3264.0
|
$0
|
3265
|
D
|
|
Stock Options (Right to Buy)
|
$33.35
|
9/4/2019
|
|
M
|
|
|
1853
|
(7)
|
2/14/2028
|
Common Stock
|
1853.0
|
$0
|
5561
|
D
|
|
Explanation of Responses:
|
(1)
|
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2019.
|
(2)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.48 to $39.94, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
|
(3)
|
The stock options vested in four equal annual installments and were fully exercisable as of December 31, 2017.
|
(4)
|
The stock options vested in four equal annual installments and were fully exercisable as of December 31, 2018.
|
(5)
|
The stock options vested at the rate of 25% on each of December 31, 2016, 2017 and 2018 with the remainder of the stock options vesting on December 31, 2019; provided that the option holder remains in continuous service through the applicable vesting date.
|
(6)
|
The stock options vested at the rate of 25% on each of December 31, 2017 and 2018 with the remainder of the stock options vesting in equal amounts on each of December 31, 2019 and 2020; provided that the option holder remains in continuous service through the applicable vesting date.
|
(7)
|
The stock options vested at the rate of 25% on the first anniversary of the grant date with the remainder of the stock options vesting in equal amounts on the second, third and fourth anniversaries of the grant date; provided that the option holder remains in continuous service through the applicable vesting date.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Ferola Peter 1000 CEDAR HOLLOW RD. SUITE 102 MALVERN, PA 19355
|
|
|
SVP & General Counsel
|
|
Signatures
|
/s/ Peter F. Ferola
|
|
9/6/2019
|
**Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
See More Message Board Posts
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.